FUNDED ACTIVITIES DESCRIPTION Sample Clauses

FUNDED ACTIVITIES DESCRIPTION. The activities funded within the project are the procurement of equipment related to the introductory scale and one equipment for the 100mL IVT scale.
Sample 1
AutoNDA by SimpleDocs
FUNDED ACTIVITIES DESCRIPTION. IPD is a Partner of the mRNA Technology Transfer Progamme convened by WHO and MPP. In the context of its Participation in the Programme, IPD has decided to establish mRNA R&D capacities in Dakar in a facility that is being repurposed for this specific objective. IPD is building capacities to implement the processes for the production of Drug Substance (DS, mRNA) and bulk Drug Product (DP, mRNA formulated in Lipid Nanoparticles) and the Analytical methods needed for the in-process testing of DS and DP and release of the final DS, DP and filled DP as developed by Afrigen (SARS CoV-2 spike protein sequence of Wuhan strain used as proof of concept mRNA). To enable the implementation of these activities, IPD will procure all the equipment needed to manufacture and test DS and DP as listed in the documentation provided by Afrigen and included in the tables included in Annex 5. This equipment will be used by IPD to produce and test batches spanning from small scale Proof of Concept batches up to technology transfer demonstration batches. The equipment will be subsequently used by IPD to conduct development activities on other vaccine candidates by using the mRNA technology.
Sample 1
FUNDED ACTIVITIES DESCRIPTION. The activities funded within this project are facilities set-up (RD250) and refurbishment (RD50), procurement and installation of equipment, procurement of raw materials and consumables, for both introductory and 100mL IVT scales, personnel costs and training, all strictly dedicated to the mRNA VACCINE TECHNOLOGY TRANSFER project.
Sample 1
FUNDED ACTIVITIES DESCRIPTION. The activities to be funded are the trainings, all strictly related to the mRNA VACCINE TECHNOLOGY TRANSFER project.
Sample 1
FUNDED ACTIVITIES DESCRIPTION. The activities to be funded within this project are the Facility furniture and refurbishment (HVAC filters), Procurement and installation of equipment - for the introductory scale, Procurement and installation of equipment – for the 100 mL IVT scale, Procurement of raw materials - introductory scale, Procurement of raw materials- 100 mL IVT scale, Procurement of consumables- introductory scale, Procurement of consumables- 100 mL IVT scale, Shipment costs, Importation taxes, Training, all strictly dedicated to mRNA VACCINE TECHNOLOGY TRANSFER project.
Sample 1

Related to FUNDED ACTIVITIES DESCRIPTION

  • INTELLECTUAL PROPERTY The Company and the Subsidiaries have, or have rights to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights necessary or required for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). None of, and neither the Company nor any Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither the Company nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

  • GRIEVANCE PROCEDURE 7.01 For purposes of this Agreement, a grievance is defined as a difference arising between the parties relating to the interpretation, application, administration or alleged violation of the Agreement including any question as to whether a matter is arbitrable.

  • WHEREAS the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange, redemption and exercise of the Warrants; and

  • General Provisions In connection with any Registration Statement and any Prospectus required by this Agreement to permit the sale or resale of Transfer Restricted Securities (including, without limitation, any Registration Statement and the related Prospectus required to permit resales of Initial Securities by Broker-Dealers), each of the Company and the Guarantors shall:

  • Definitions As used in this Agreement, the following terms shall have the following meanings:

  • Dispute Resolution All or any disputes arising out or touching upon or in relation to the terms and conditions of this Agreement, including the interpretation and validity of the terms thereof and the respective rights and obligations of the Parties, shall be settled amicably by mutual discussion, failing which the same shall be settled through the adjudicating officer appointed under the Act.

  • Term of Agreement This Agreement shall continue in full force and effect until the tenth (10th) anniversary of Bank Closing; provided, that the provisions of Section 6.3 and 6.4 shall survive the expiration of the term of this Agreement; and provided further, that the receivership of the Failed Bank may be terminated prior to the expiration of the term of this Agreement, and in such event, the guaranty of the Corporation, as provided in and in accordance with the provisions of Section 12.7 shall be in effect for the remainder of the term of this Agreement. Expiration of the term of this Agreement shall not affect any claim or liability of any party with respect to any (i) amount which is owing at the time of such expiration, regardless of when such amount becomes payable, and (ii) breach of this Agreement occurring prior to such expiration, regardless of when such breach is discovered.

  • Amendments This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties hereto.

  • Independent Contractor The Contractor and its employees, agents, representatives, and subcontractors are independent contractors and not employees or agents of the State of Florida and are not entitled to State of Florida benefits. The Department and Customer will not be bound by any acts or conduct of the Contractor or its employees, agents, representatives, or subcontractors. The Contractor agrees to include this provision in all its subcontracts under the Contract.

  • Termination This Agreement may be terminated at any time prior to the Closing:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!